Literature DB >> 17408659

Lectin conjugates as potent, nonabsorbable CFTR inhibitors for reducing intestinal fluid secretion in cholera.

N D Sonawane1, Dan Zhao, Olga Zegarra-Moran, Luis J V Galietta, A S Verkman.   

Abstract

BACKGROUND & AIMS: Inhibitors of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel are predicted to prevent intestinal fluid secretion in cholera. We previously discovered low- affinity glycine hydrazide (GlyH) CFTR inhibitors that block CFTR at its external pore. The goal of this study was to develop potent CFTR inhibitors that are minimally absorbed and washed out of the intestinal lumen for application as antisecretory agents in cholera.
METHODS: GlyH analogs (malonic hydrazides, MalH) were chemically conjugated to various lectins ("MalH-lectin") and purified. CFTR inhibition potency was measured by short-circuit current analysis, mechanism of action by patch-clamp, and antidiarrheal efficacy in closed-loop and suckling mouse models.
RESULTS: By lectin conjugation, we improved CFTR inhibitory potency by approximately 100-fold (to 50 nmol/L) and retarded washout. High-affinity CFTR inhibition was abolished by MalH-lectin heat denaturation, protease digestion, or competition by mannose or unconjugated lectin. Patch-clamp analysis indicated CFTR inhibition by an external pore occlusion mechanism. Fluorescently labeled MalH-lectin remained membrane bound for >6 hours after washout, whereas washout occurred in a few minutes without the lectin. MalH-ConA and MalH-wheat (IC50 50-100 pmol) blocked cholera toxin-induced intestinal fluid secretion in closed intestinal loops in mice and greatly reduced mortality in a suckling mouse model of cholera.
CONCLUSIONS: The high potency of MalH-lectin conjugates results from "anchoring" the CFTR-blocking MalH to cell surface carbohydrates by the lectin. The high-affinity, slow washout, and external site of action of the MalH-lectin conjugates support their further development as antisecretory drugs for enterotoxin-mediated secretory diarrheas.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17408659     DOI: 10.1053/j.gastro.2007.02.018

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  30 in total

Review 1.  Chloride channel-targeted therapy for secretory diarrheas.

Authors:  Jay R Thiagarajah; A S Verkman
Journal:  Curr Opin Pharmacol       Date:  2013-08-27       Impact factor: 5.547

Review 2.  Chloride channels as drug targets.

Authors:  Alan S Verkman; Luis J V Galietta
Journal:  Nat Rev Drug Discov       Date:  2008-01-19       Impact factor: 84.694

3.  Nanomolar potency pyrimido-pyrrolo-quinoxalinedione CFTR inhibitor reduces cyst size in a polycystic kidney disease model.

Authors:  Lukmanee Tradtrantip; N D Sonawane; Wan Namkung; A S Verkman
Journal:  J Med Chem       Date:  2009-10-22       Impact factor: 7.446

4.  Benzopyrimido-pyrrolo-oxazine-dione (R)-BPO-27 Inhibits CFTR Chloride Channel Gating by Competition with ATP.

Authors:  Yonjung Kim; Marc O Anderson; Jinhong Park; Min Goo Lee; Wan Namkung; A S Verkman
Journal:  Mol Pharmacol       Date:  2015-07-14       Impact factor: 4.436

5.  Rotavirus toxin NSP4 induces diarrhea by activation of TMEM16A and inhibition of Na+ absorption.

Authors:  Jiraporn Ousingsawat; Myriam Mirza; Yuemin Tian; Eleni Roussa; Rainer Schreiber; David I Cook; Karl Kunzelmann
Journal:  Pflugers Arch       Date:  2011-03-12       Impact factor: 3.657

Review 6.  CFTR pharmacology.

Authors:  Olga Zegarra-Moran; Luis J V Galietta
Journal:  Cell Mol Life Sci       Date:  2016-10-04       Impact factor: 9.261

Review 7.  Cystic fibrosis transmembrane conductance regulator chloride channel blockers: Pharmacological, biophysical and physiological relevance.

Authors:  Paul Linsdell
Journal:  World J Biol Chem       Date:  2014-02-26

8.  Small-molecule CFTR inhibitors slow cyst growth in polycystic kidney disease.

Authors:  Baoxue Yang; Nitin D Sonawane; Dan Zhao; Stefan Somlo; A S Verkman
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

9.  Thiazolidinone CFTR inhibitors with improved water solubility identified by structure-activity analysis.

Authors:  N D Sonawane; A S Verkman
Journal:  Bioorg Med Chem       Date:  2008-07-23       Impact factor: 3.641

Review 10.  CFTR inhibitors.

Authors:  Alan S Verkman; David Synder; Lukmanee Tradtrantip; Jay R Thiagarajah; Marc O Anderson
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.